The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
Open accessAbstract
The phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway is critical for cellular growth and metabolism. Correspondingly, loss of function of PTEN, a negative regulator of PI3K, or activating mutations in AKT1, AKT2 or AKT3 have been found in distinct disorders featuring overgrowth or hypoglycemia. We performed exome sequencing of DNA from unaffected and affected cells from an individual with an unclassified syndrome of congenital progressive segmental overgrowth of fibrous and adipose tissue and bone and identified the cancer-associated mutation encoding p.His1047Leu in PIK3CA, the gene that encodes the p110α catalytic subunit of PI3K, only in affected cells. Sequencing of PIK3CA in ten additional individuals with overlapping syndromes identified either the p.His1047Leu alteration or a second cancer-associated alteration, p.His1047Arg, in nine cases. Affected dermal fibroblasts showed enhanced basal and epidermal growth factor (EGF)-stimulated phosphatidylinositol 3,4,5-trisphosphate (PIP3) generation and concomitant activation of downstream signaling relative to their unaffected counterparts. Our findings characterize a distinct overgrowth syndrome, biochemically demonstrate activation of PI3K signaling and thereby identify a rational therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Engelman, J. A., Chen, L., Tan, X., Crosby, K., Guimaraes, A. R., Upadhyay, R., Maira, M., McNamara, K., Perera, S. A., Song, Y., et al. (2008) · Nature Medicine · doi:10.1038/nm.1890 · Cited by 1,330
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
Carpten, J. D., Faber, A. L., Horn, C., Donoho, G. P., Briggs, S. L., Robbins, C. M., Hostetter, G., Boguslawski, S., Moses, T. Y., Savage, S., et al. (2007) · Nature · doi:10.1038/nature05933 · Cited by 1,292
Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
Chen, W. S., Xu, P.-Z., Gottlob, K., Chen, M.-L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., et al. (2001) · Genes & Development · doi:10.1101/gad.913901 · Cited by 928
A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome
Lindhurst, M. J., Sapp, J. C., Teer, J. K., Johnston, J. J., Finn, E. M., Peters, K., Turner, J., Cannons, J. L., Bick, D., Blakemore, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104017 · Cited by 903
Self-citationFirmann, M., Mayor, V., Vidal, P. M., Bochud, M., Pécoud, A., Hayoz, D., Paccaud, F., Preisig, M., Song, K. S., Yuan, X., et al. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-6 · Cited by 721
Role of Akt/protein kinase B in metabolism
Whiteman, E. L., Cho, H., & Birnbaum, M. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00662-8 · Cited by 676
Signalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540
Somatic activation of AKT3 causes hemispheric developmental brain malformations
Poduri, A., Evrony, G. D., Cai, X., Elhosary, P. C., Beroukhim, R., Lehtinen, M. K., Hills, L. B., Heinzen, E. L., Hill, A., Hill, R. S., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.010 · Cited by 478
Proteus syndrome: Diagnostic criteria, differential diagnosis, and patient evaluation
Biesecker, L. G., Happle, R., Mulliken, J. B., Weksberg, R., Graham, J. M., Viljoen, D. L., & Cohen, M. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990611)84:5<389::aid-ajmg1>3.0.co;2-o · Cited by 421
Self-citationQuantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry
Clark, J., Anderson, K. E., Juvin, V., Smith, T. S., Karpe, F., Wakelam, M. J. O., Stephens, L. R., & Hawkins, P. T. (2011) · Nature Methods · doi:10.1038/nmeth.1564 · Cited by 295
Self-citationA frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane
Mandelker, D., Gabelli, S. B., Schmidt-Kittler, O., Zhu, J., Cheong, I., Huang, C.-H., Kinzler, K. W., Vogelstein, B., & Amzel, L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908444106 · Cited by 293
Liu, P., Cheng, H., Santiago, S., Raeder, M., Zhang, F., Isabella, A., Yang, J., Semaan, D. J., Chen, C., Fox, E. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2402 · Cited by 257
The group of epidermal nevus syndromes
Happle, R. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.01.017 · Cited by 223
A Fresh Look at Semipresidentialism: Variations on a Theme
Elgie, R. (2005) · Journal of Democracy · doi:10.1353/jod.2005.0045 · Cited by 215
Kinross, K. M., Montgomery, K. G., Kleinschmidt, M., Waring, P., Ivetac, I., Tikoo, A., Saad, M., Hare, L., Roh, V., Mantamadiotis, T., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59309 · Cited by 214
Hafner, C., López-Knowles, E., Luis, N. M., Toll, A., Baselga, E., Fernández-Casado, A., Hernández, S., Ribé, A., Mentzel, T., Stoehr, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705218104 · Cited by 209
The group of epidermal nevus syndromes
Happle, R. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.01.016 · Cited by 182
An Activating Mutation of AKT2 and Human Hypoglycemia
Hussain, K., Challis, B., Rocha, N., Payne, F., Minic, M., Thompson, A., Daly, A., Scott, C., Harris, J., Smillie, B. J. L., et al. (2011) · Science · doi:10.1126/science.1210878 · Cited by 178
Self-citationCooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
Adams, J. R., Xu, K., Liu, J. C., Agamez, N. M. R., Loch, A. J., Wong, R. G., Wang, W., Wright, K. L., Lane, T. F., Zacksenhaus, E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0738 · Cited by 163
Yamamoto, S., Tsuda, H., Takano, M., Iwaya, K., Tamai, S., & Matsubara, O. (2011) · The Journal of Pathology · doi:10.1002/path.2940 · Cited by 152
Rapamycin treatment for a child with germline PTEN mutation
Marsh, D. J., Trahair, T. N., Martin, J. L., Chee, W. Y., Walker, J. L., Kirk, E. P., Baxter, R. C., & Marshall, G. M. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1112 · Cited by 143
PIK3CA Mutations in In situ and Invasive Breast Carcinomas
Miron, A., Varadi, M., Carrasco, D. R., Li, H., Luongo, L., Kim, H. J., Park, S. Y., Cho, E. Y., Lewis, G., Kehoe, S. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-08-2660 · Cited by 135
Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases
Hon, W.-C., Berndt, A., & Williams, R. L. (2012) · Oncogene · doi:10.1038/onc.2011.532 · Cited by 129
Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
Meyer, D. S., Brinkhaus, H., Müller, U., Müller, M., Cardiff, R. D., & Bentires‐Alj, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3827 · Cited by 125
Next generation sequencing--implications for clinical practice
Raffan, E., & Semple, R. K. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr029 · Cited by 68
Self-citationAssessment and management of the orthopedic and other complications of Proteus syndrome
Tosi, L. L., Sapp, J. C., Allen, E. S., O’Keefe, R. J., & Biesecker, L. G. (2011) · Journal of Children s Orthopaedics · doi:10.1007/s11832-011-0350-6 · Cited by 37
Self-citationA proposal for classification of entities combining vascular malformations and deregulated growth
Oduber, C. E. U., van der Horst, C. M. A. M., Smitt, J. H. S., Smeulders, M. J. C., Mendiratta, V., Harper, J. I., Steensel, M. A. M. V., & Hennekam, R. C. M. (2011) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2011.02.007 · Cited by 22
Cited by
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
Single-cell genome sequencing: current state of the science
Gawad, C., Koh, W., & Quake, S. R. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.16 · Cited by 1,334
A genomic view of mosaicism and human disease
Biesecker, L. G., & Spinner, N. B. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3424 · Cited by 619
Self-citationBrioude, F., Kalish, J. M., Mussa, A., Foster, A. C., Bliek, J., Ferrero, G. B., Boonen, S. E., Cole, T., Baker, R., Bertoletti, M., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.166 · Cited by 603
Somatic mutation, genomic variation, and neurological disease
Poduri, A., Evrony, G. D., Cai, X., & Walsh, C. A. (2013) · Science · doi:10.1126/science.1237758 · Cited by 584
Metadata
- Authors
- Lindhurst, M. J., Parker, V. E. R., Payne, F., Sapp, J. C., Rudge, S., Harris, J., Witkowski, A. M., Zhang, Q., Groeneveld, M. P., Scott, C. E., Daly, A., Huson, S. M., Tosi, L. L., Cunningham, M. L., Darling, T. N., Geer, J., Gucev, Z., Sutton, V. R., Tziotzios, C., Dixon, A. K., Helliwell, T., O'Rahilly, S., Savage, D. B., Wakelam, M. J. O., Barroso, I., Biesecker, L. G., & Semple, R. K.
- Venue
- Nature Genetics
- Published
- 2012-06-24
- Volume
- 44
- Issue
- 8
- Pages
- 928-933
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2089620648
- Cited by
- 325
- References
- 30
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.